Clal Biotechnology | CBI - PE Price to Earnings

Stock Price
31.90
Daily Change
1.00 3.24%
Monthly
5.63%
Yearly
5.28%
Q2 Forecast
29.98

Clal Biotechnology reported 11.67 in PE Price to Earnings for its fiscal quarter ending in December of 2022.





Pe Change Date
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 4.06 75.75 Dec/2025
RedHill Biopharma 0.04 0.03 Jun/2025
TherapeuticsMD 0.75 3.3 Mar/2023